About Hyfe
Hyfe is a digital health company that specializes in AI-powered cough detection, tracking, and classification. The company’s core technology utilizes acoustic artificial intelligence to passively and continuously monitor cough frequency and patterns in real-world settings. This on-device AI processing ensures patient privacy by detecting coughs locally and only transmitting metadata (timestamps) rather than recording or storing audio.
For physicians, Hyfe offers a validated platform to gain objective, continuous, and longitudinal cough data, which has historically been difficult to measure reliably. This data can be used as an endpoint in clinical trials for drug and device development, enabling more sensitive detection of treatment effects and advancing respiratory research beyond subjective patient reports. Hyfe’s technology is also designed to empower healthcare providers to optimize patient care and support digital therapeutics for managing respiratory illnesses, including chronic cough. The company has partnerships with leading academic institutions like Johns Hopkins University and the University of California at San Francisco, and its technology has been used in over 50 clinical studies.
Focus Areas
Business Intelligence
| Key Investors | Mubadala Capital, Dreamit Ventures, OnDeck, Techstars |
| Partnerships | University of Cambridge, Imperial College London, Mayo Clinic, University of Florida, Northwestern University |
| Acquisitions | unknown |
| Technology | Cloud-native AI platform, edge computing capabilities for real-time sound analysis, proprietary cough detection algorithms |
What Physicians Need to Know
For physicians, Hyfe offers a significant advancement by providing objective, continuous, and quantitative cough data, moving beyond unreliable subjective patient reports. This data can improve diagnostics, disease management, and treatment efficacy assessment for conditions where cough is a key symptom, such as chronic cough, COPD, asthma, and congestive heart failure. The privacy-preserving nature of their on-device AI ensures patient comfort and regulatory compliance, making it a practical tool for long-term monitoring in both clinical and remote settings. The ability to integrate with telehealth platforms and provide real-time insights can lead to more personalized treatment plans and enhanced patient care.
Hyfe's structured, time-stamped outputs can be integrated into Electronic Data Capture (EDC) systems, aligned with eCOA timestamps, or incorporated into centralized data repositories. They support various integration models, including direct monitoring as a service, licensed deployment within clinical trials, strategic partnerships for broader therapeutic strategies, and embedding within third-party digital health or wearable platforms. Notable partnerships include integration with ObvioHealth's decentralized clinical trials platform and ActiGraph's FDA-cleared LEAP wearable for clinical research. They also partner with pharmaceutical companies like Merck for consumer disease education efforts.
Reviews & Opinions
Videos
News, demos, and interviews about Hyfe.
Videos load interactively. If none appear, search YouTube for Hyfe →
Press & Coverage
Frequently Asked Questions
Investors
Who's funded Hyfe.
Related Companies
Teladoc Health is a global leader in whole-person virtual care, leveraging technology and data to deliver comprehensive healthcare services. For physicians, Teladoc Health offers a robust platform designed to facilitate high-quality remote care, enabling connections with patients across diverse needs, settings, and time zones. The company’s solutions support clinicians with advanced tools and insights, utilizing […]
AstraZeneca PLC is a British-Swedish multinational pharmaceutical and biotechnology company that focuses on the discovery, development, and commercialization of prescription medicines. The company’s portfolio addresses major diseases in areas such as oncology, rare diseases, and biopharmaceuticals, which include cardiovascular, renal & metabolism, and respiratory & immunology. AstraZeneca operates globally, with a significant commercial presence in […]
Google DeepMind is a leading artificial intelligence (AI) research laboratory, a subsidiary of Alphabet Inc., dedicated to developing advanced AI systems to benefit humanity. The company focuses on creating general-purpose AI that can learn and solve complex problems, drawing inspiration from neuroscience and machine learning. Their work spans various fields, including healthcare, scientific discovery, and […]
Tempus AI is a leading health technology company that leverages artificial intelligence (AI) and machine learning to advance precision medicine. Founded in 2015 by Eric Lefkofsky, the company was inspired by the need for more data-driven approaches in oncology care. Tempus has since built one of the world’s largest libraries of multimodal clinical and molecular […]
MyTrials.ai is a healthcare AI company dedicated to revolutionizing access to clinical trials for patients and streamlining recruitment for researchers. The platform leverages artificial intelligence and clinical expertise to match patients with suitable clinical trials based on their health profiles, preferences, and values. This approach aims to simplify complex medical information, making it easier for […]
LabLynx is a privately held American laboratory informatics company that specializes in developing, supporting, and marketing Laboratory Information Management System (LIMS) solutions. The company has a long history in the industry, having introduced one of the first browser-based LIMS products in 1997. LabLynx’s primary offerings include ELab LIMS, a configurable cloud-based LIMS that serves various […]